The Early Bird

The Life of  Scott Rocklage

Dr. Scott Rocklage has been a managing partner at 5AM Ventures since 2004. He began with the company in the previous year as a partner. Read more: Scott Racklage | Crunchbase

He is a well-renowned leader in the world of biopharmaceuticals and has extensive healthcare management experience. He also assists entrepreneurs in the business, medical and science fields. He is based in Boston.

He has a Bachelor’s Degree in Chemistry from the University of California at Berkeley as well as a P.H.D in the same field from the Massachusettes Institute of Technology.

Dr. Scott Rocklage has been instrumental in the passage of three new U.S. drug applications. They are Omniscan, Telescan, and Cubicin. With his help, many other drugs have gone into clinical trials.

Dr. Scott Rocklage has served on many Boards and helped with many research and development projects. He currently serves on the Boards of Rennovia, Kinestral, and Cidara.

He works on the Boards of Epirus and Pulmatrix as well. He was a former Chairman of Ilypsa, Miikana, and Sempus which were acquired by other companies. Learn more about Nathaniel Ru:

For Dr. Rocklage however, 5AM Ventures is probably his most rewarding position. 5AM Ventures helps entrepreneurs starting out in the field of life science.

The reason the company is called 5AM Ventures is that it helps with the beginning phases of new businesses in the fields of life science.

Dr. Rocklage continues to strive in his chosen field of study. He advises people to not be afraid of risks and hopes to one day see the end of cancer as we know it. With Dr. Rocklage at the helm, it will happen sooner than we think.